Literature DB >> 15251081

Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

David Kane1, Oliver FitzGerald.   

Abstract

The successful introduction of anti-tumor necrosis factor (TNF) therapies in psoriasis and psoriatic arthritis has sharpened considerable interest in this chronic and frequently disabling disease. Unlike the situation in rheumatoid arthritis, where anti-TNF therapies were introduced after years of painstaking research which confirmed a key proinflammatory role for TNF, the evidence for TNF having a key role in psoriatic arthritis has lagged behind. In this paper, the emerging immunohistochemical, genetic, and clinical literature relating to TNF's role in skin and joint manifestations of this disease is reviewed and areas for future research are suggested.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15251081     DOI： 10.1007/s11926-004-0041-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  62 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Authors:  U Chaudhari; P Romano; L D Mulcahy; L T Dooley; D G Baker; A B Gottlieb
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

3.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

4.  Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.

Authors:  A L Ogilvie; C Antoni; C Dechant; B Manger; J R Kalden; G Schuler; M Lüftl
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

5.  Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis.

Authors:  T Höhler; S Grossmann; B Stradmann-Bellinghausen; W Kaluza; E Reuss; K de Vlam; E Veys; E Märker-Hermann
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

6.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

7.  Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.

Authors:  C Haworth; F M Brennan; D Chantry; M Turner; R N Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

Review 10.  Genetic epidemiology. Psoriatic arthritis.

Authors:  Anne C Barton
Journal:  Arthritis Res       Date:  2002-01-31
View more
  10 in total

Review 1.  The role of ultrasound in the diagnosis and management of psoriatic arthritis.

Authors:  David Kane
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

2.  TNFalpha polymorphisms and risk of psoriatic arthritis.

Authors:  P Rahman; F Siannis; C Butt; V Farewell; L Peddle; F Pellett; D Gladman
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

Review 3.  Immunopathology of psoriasis and psoriatic arthritis.

Authors:  D J Veale; C Ritchlin; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

4.  TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis.

Authors:  Giuseppe Murdaca; Rossella Gulli; Francesca Spanò; Francesca Lantieri; Martina Burlando; Aurora Parodi; Paola Mandich; Francesco Puppo
Journal:  J Invest Dermatol       Date:  2014-03-04       Impact factor: 8.551

5.  Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint.

Authors:  Ugo Fiocco; Paolo Sfriso; Francesca Oliviero; Pascale Roux-Lombard; Elena Scagliori; Luisella Cozzi; Francesca Lunardi; Fiorella Calabrese; Maristella Vezzù; Serena Dainese; Beatrice Molena; Anna Scanu; Roberto Nardacchione; Leopoldo Rubaltelli; Jean Michel Dayer; Leonardo Punzi
Journal:  Arthritis Res Ther       Date:  2010-07-19       Impact factor: 5.156

6.  Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Authors:  Paola Cordiali-Fei; Elisabetta Trento; Giovanna D'Agosto; Valentina Bordignon; Anna Mussi; Marco Ardigò; Antonio Mastroianni; Antonella Vento; Francesco Solivetti; Enzo Berardesca; Fabrizio Ensoli
Journal:  J Autoimmune Dis       Date:  2006-10-05

7.  Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis.

Authors:  Junqing Zhu; Hongda Qu; Xiaoguang Chen; Hao Wang; Juan Li
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

8.  Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease.

Authors:  Sumeha Arora; Indu Pal Kaur; Kanwaljit Chopra; Praveen Rishi
Journal:  Mediators Inflamm       Date:  2014-05-22       Impact factor: 4.711

Review 9.  TNF-α gene polymorphisms and expression.

Authors:  Radwa R El-Tahan; Ahmed M Ghoneim; Noha El-Mashad
Journal:  Springerplus       Date:  2016-09-07

10.  Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis.

Authors:  Hani A Al-Shobaili; Jalees Farhan; Uzma Zafar; Zafar Rasheed
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.